Zobrazeno 1 - 10 of 12 pro vyhledávání: '"Miguel Fodor"'
1
Plasma Sarcosine Measured by Gas Chromatography-Mass Spectrometry Distinguishes Prostatic Intraepithelial Neoplasia and Prostate Cancer from Benign Prostate Hyperplasia
Autor: Natalia V Potoldykova, Pavel A. Markin, Ekaterina V. Lartsova, Svetlana A. Appolonova, Miguel Fodor, A. V. Lyundup, Yevgeny V. Shpot, Natalia E. Moskaleva, Vasily Y. Mikhajlov, Dimitry V. Enikeev, Alex Brito, Yulia V. Lerner
Publikováno v: Laboratory medicine. 51(6)
Objective Sarcosine was postulated in 2009 as a biomarker for prostate cancer (PCa). Here, we assess plasma sarcosine as a biomarker that is complementary to prostate-specific antigen (PSA). Methods Plasma sarcosine was measured using gas chromatogra
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b11fc0a182867c41b49d8b86d5e2a76
https://pubmed.ncbi.nlm.nih.gov/32161964
Zobrazit plný text záznamu
2
Quality of Life With Docetaxel Plus Cisplatin and Fluorouracil Compared With Cisplatin and Fluorouracil From a Phase III Trial for Advanced Gastric or Gastroesophageal Adenocarcinoma: The V-325 Study Group
Autor: Lucile Awad, Sergei Tjulandin, Miguel Fodor, Eric Van Cutsem, Edouard Voznyi, Vladimir Moiseyenko, Manuel Constenla, Corrado Boni, Yee Chao, Jaffer A. Ajani, Alejandro Majlis, Adriano Rodrigues
Publikováno v: Journal of Clinical Oncology. 25:3210-3216
Purpose Therapy of patients with advanced gastric or gastroesophageal junction cancer should provide symptom relief and improve quality of life (QOL) because most patients are symptomatic at baseline. Using validated instruments, we prospectively ass
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12091fe1f5747770adf3ac5e250faf22
https://doi.org/10.1200/jco.2006.08.3956
Zobrazit plný text záznamu
3
Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group
Autor: Manuel Constenla, Yee Chao, Vladimir M. Moiseyenko, Adriano Rodrigues, Corrado Boni, Alejandro Majlis, Sergei Tjulandin, Edouard Voznyi, Marie Laure Risse, Eric Van Cutsem, Miguel Fodor, Jaffer A. Ajani
Publikováno v: Journal of Clinical Oncology. 24:4991-4997
Purpose In the randomized, multinational phase II/III trial (V325) of untreated advanced gastric cancer patients, the phase II part selected docetaxel, cisplatin, and fluorouracil (DCF) over docetaxel and cisplatin for comparison against cisplatin an
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be68b0d551c71d94b029cbb99b8a33aa
https://doi.org/10.1200/jco.2006.06.8429
Zobrazit plný text záznamu
4
Dendritic cell immunizations alone or combined with low doses of interleukin-2 induce specific immune responses in melanoma patients
Autor: Adam Aguirre, Marcos Ramírez, Alejandro Escobar, Roberto González, Milton Larrondo, Mercedes N. López, Antonio Serrano, Miguel Fodor, Claudio A. Perez, Jorge Alfaro, Carlos Ferrada, Flavio Salazar-Onfray
Publikováno v: CLINICAL AND EXPERIMENTAL IMMUNOLOGY
Artículos CONICYT
CONICYT Chile
instacron:CONICYT
SummaryDendritic cell (DC)-based therapy has proved to be effective in patients with a variety of malignancies. However, an optimal immunization protocol using DCs and the best means for delivering antigens has not yet been described. In this study,
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f68af35499535ad8663007fb73a7c069
https://doi.org/10.1111/j.1365-2249.2005.02948.x
Zobrazit plný text záznamu
5
A phase I, II study of high-dose 5-fluorouracil and high-dose leucovorin with low-dose phosphonacetyl-L-aspartic acid in patients with advanced malignancies
Autor: L Morrell, Lynn G. Feun, Bach Ardalan, Stephen P. Richman, Stuart Waldman, Kasi S. Sridhar, Alan S. Livingstone, Niramol Savaraj, Pasquale Benedetto, Miguel Fodor
Publikováno v: Cancer. 68:1242-1246
Twenty-eight patients with refractory advanced malignancies were treated with a 24-hour infusion of 5-fluorouracil (5-FU), leucovorin (LV), and N-(phosphonacetyl)-L-aspartic acid (PALA) weekly. Twenty-seven patients were evaluable to assess toxicity
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3902c591becdf69a56a0c226455f794c
https://doi.org/10.1002/1097-0142(19910915)68:6<1242::aid-cncr2820680610>3.0.co
Zobrazit plný text záznamu
6
Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase III trial of advanced gastric or gastroesophageal cancer adenocarcinoma: the V-325 Study Group
Autor: Vladimir Moiseyenko, Sergei Tjulandin, Edouard Voznyi, Yee Chao, Jaffer A. Ajani, Cindy Marabotti, Alejandro Majlis, Eric Van Cutsem, Manuel Constenla, Adriano Rodrigues, Corrado Boni, Miguel Fodor
Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 25(22)
Purpose For patients with advanced gastric or gastroesophageal cancer (AGGEC) providing clinical benefit with improved palliation is highly desirable. However, a prospective evaluation of clinical benefit in AGGEC patients has never before been repor
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8dad0af02197e1ad8e2c640fa57f8908
https://pubmed.ncbi.nlm.nih.gov/18253105
Zobrazit plný text záznamu
7
[Advances in cellular immunotherapy for malignant melanoma]
Autor: Mercedes, López, Alejandro, Escobar, Jorge, Alfaro, Miguel, Fodor, Milton, Larrondo, Carlos, Ferrada, Flavio, Salazar-Onfray
Publikováno v: Revista medica de Chile. 132(9)
An alternative strategy for cancer treatment is the manipulation of the immune system, denominated cancer immunotherapy. The immunotherapeutical use of cells of the immune system, like dendritic cells (DC), is being explored in different clinical pro
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1653832b8cc4967d6b888721ae96b7e6
https://pubmed.ncbi.nlm.nih.gov/15543770
Zobrazit plný text záznamu
8
Avances en inmunoterapia celular contra el melanoma maligno
Autor: Milton Larrondo, Flavio Salazar-Onfray, Mercedes N. López, Carlos Ferrada, Alejandro Escobar, Jorge Alfaro, Miguel Fodor
Publikováno v: Revista médica de Chile. 132
An alternative strategy for cancer treatment is the manipulation of the immune system, denominated cancer immunotherapy. The immunotherapeutical use of cells of the immune system, like dendritic cells (DC), is being explored in different clinical pro
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3bf3d58e7aa6cc2b460cd3970a1afb8c
https://doi.org/10.4067/s0034-98872004000900014
Zobrazit plný text záznamu
9
A phase II study of gemcitabine in gallbladder carcinoma
Autor: M. Yanez, Claudia Gamargo, B. Rubio, Luis Orlandi, Miguel Fodor, Jorge Gallardo, Monica Ahumada
Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology. 12(10)
Background: Due to the high mortality rates from gallbladder carcinoma in Chile, we conducted a phase II trial to test the efficacy and safety of gemcitabine in patients with locally advanced or metastatic gallbladder carcinoma. Patients and methods:
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ca50e363637c70d455f0668e51a30d6
https://pubmed.ncbi.nlm.nih.gov/12075753
Zobrazit plný text záznamu
10
El enfermo terminal
Autor: Miguel Fodor B.
Publikováno v: Revista médica de Chile v.128 n.9 2000
SciELO Chile
CONICYT Chile
instacron:CONICYT
Revista médica de Chile, Volume: 128, Issue: 9, Pages: 1063-1064, Published: SEP 2000
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d83f5702bf0f0d10f4b5af0d9fbea295
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872000000900017
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje